Decisions Guided Through a Bioethical Lens
COVID-19 Update: Your Latest Questions About Johnson & Johnson's Investigational Vaccine Candidate AnsweredDid you like reading this story? Click the heart to show your love.
The COVID-19 Data Plan: 3 Innovative Ways Johnson & Johnson Is Using Data Science to Fight the PandemicDid you like reading this story? Click the heart to show your love.
A Message from Chairman and CEO Alex Gorsky About Johnson & Johnson's Investigational COVID-19 Vaccine CandidateDid you like reading this message? Click the heart to show your love.
Bioethics is an applied discipline that takes the principles of ethics and applies them to biological research, science and medicine. Adherence to bioethical principles, including transparency, integrity and respect for the rights and welfare of all persons, stems from Our Credo values and the commitment we make to our patients and consumers.
Johnson & Johnson is recognized as an industry leader in championing ethical decision-making and policies within R&D. Our efforts in compassionate use through the CompAC initiative—a groundbreaking collaboration launched with the NYU School of Medicine in 2015—ensures fair, objective and ethical evaluations of patient requests for investigational medicine. In addition, we are a leader in initiatives to improve clinical trial data transparency through the Yale University Open Data Access (YODA) Project––a data-sharing model that provides a fair and unbiased approach for assessing external requests for the use of data from the Johnson & Johnson Family of Companies.
An Ethical Code of Conduct for R&D
A complement to Our Credo, Our Ethical Code for the Conduct of Research and Development provides standards of conduct and behavior for physicians, clinical research scientists and others responsible for medical aspects of research and development. It provides principles that guide ethical decision-making around the use of our products, and the best interests of our patients, their families, doctors, nurses and healthcare providers.
Johnson & Johnson is strongly committed to ensuring that our employees have both the resources and training to help them address difficult and complex bioethical questions that may arise during the course of their day to day work. To address the complex ethical questions arising in the field of biological research, science and medicine, our global Johnson & Johnson Bioethics Committee (JJBC), sponsored by the Johnson & Johnson Office of the Chief Medical Officer (OCMO), serves as an advisory body to our global teams on ethical issues. Composed of a diverse group of internal experts with training and experience in evaluating bioethical questions, the JJBC is responsible for advocating adherence to bioethical principles, providing an expert forum for teams to obtain guidance on bioethical issues and for championing our commitment to ethical decision making across the enterprise. JJBC is guided by the fundamental principles of bioethics, including beneficence, non-maleficence, autonomy and justice, as well as our Ethical Code for the Conduct of Research and Development.
Adherence to Our Credo helps us more effectively integrate bioethics into scientific innovation, enabling us to pioneer initiatives and policies that actively shape our actions as a trusted leadership voice.